# Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment

> **NCT05732272** · PHASE3 · RECRUITING · sponsor: **University of Kansas Medical Center** · enrollment: 500 (estimated)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Bupropion

## Key facts

- **NCT ID:** NCT05732272
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-28
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-04-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05732272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05732272, "Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05732272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*